Issue 2/2015
Content (22 Articles)
BI-RADS update for breast cancer caregivers
Emily L. Sedgwick, Lilian Ebuoma, Anthony Hamame, Kanchan Phalak, Lorell Ruiz-Flores, Tamara Ortiz-Perez, Karla A. Sepulveda
Cancer-mediated adipose reversion promotes cancer cell migration via IL-6 and MCP-1
Kaoru Fujisaki, Hiroshi Fujimoto, Takafumi Sangai, Takeshi Nagashima, Masahiro Sakakibara, Nobumitsu Shiina, Masayuki Kuroda, Yasuyuki Aoyagi, Masaru Miyazaki
Inhibition of BET proteins impairs estrogen-mediated growth and transcription in breast cancers by pausing RNA polymerase advancement
Surojeet Sengupta, Michael C. Biarnes, Robert Clarke, V. Craig Jordan
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial
Ramona Erber, Oleg Gluz, Nils Brünner, Hans Heinrich Kreipe, Enrico Pelz, Ronald Kates, Annette Bartels, Jens Huober, Svjetlana Mohrmann, Zehra Moustafa, Cornelia Liedtke, Volker Möbus, Doris Augustin, Christoph Thomssen, Fritz Jänicke, Marion Kiechle, Walther Kuhn, Ulrike Nitz, Nadia Harbeck, Arndt Hartmann
Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic
Lise B. Ahlborn, Mette Dandanell, Ane Y. Steffensen, Lars Jønson, Finn C. Nielsen, Thomas v. O. Hansen
PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients
Chiya Oshiro, Naofumi Kagara, Yasuto Naoi, Masafumi Shimoda, Atsushi Shimomura, Naomi Maruyama, Kenzo Shimazu, Seung Jin Kim, Shinzaburo Noguchi
The CCL2 chemokine is a negative regulator of autophagy and necrosis in luminal B breast cancer cells
Wei Bin Fang, Min Yao, Iman Jokar, Nabil Alhakamy, Cory Berkland, Jin Chen, Dana Brantley-Sieders, Nikki Cheng
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer
Callie R. Merry, Sarah McMahon, Cheryl L. Thompson, Kristy L. S. Miskimen, Lyndsay N. Harris, Ahmad M. Khalil
Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer
Rezvan Abduljabbar, Ola H. Negm, Chun-Fui Lai, Dena A. Jerjees, Methaq Al-Kaabi, Mohamed R. Hamed, Patrick J. Tighe, Lakjaya Buluwela, Abhik Mukherjee, Andrew R. Green, Simak Ali, Emad A. Rakha, Ian O. Ellis
Pnck overexpression in HER-2 gene-amplified breast cancer causes Trastuzumab resistance through a paradoxical PTEN-mediated process
Tushar B. Deb, Annie H. Zuo, Robert J. Barndt, Surojeet Sengupta, Radmila Jankovic, Michael D. Johnson
High tumor budding stratifies breast cancer with metastatic properties
Bodour Salhia, Mafalda Trippel, Katrin Pfaltz, Nikola Cihoric, André Grogg, Claudia Lädrach, Inti Zlobec, Coya Tapia
A nomogram based on mammary ductoscopic indicators for evaluating the risk of breast cancer in intraductal neoplasms with nipple discharge
Zhen-Qiang Lian, Qi Wang, An-Qin Zhang, Jiang-Yu Zhang, Xiao-Rong Han, Hai-Yun Yu, Si-Mei Xie
The impact of breast cancer-related lymphedema on the ability to perform upper extremity activities of daily living
Jean A. O’Toole, Chantal M. Ferguson, Meyha N. Swaroop, Nora Horick, Melissa N. Skolny, Cheryl L. Brunelle, Cynthia L. Miller, Lauren S. Jammallo, Michelle C. Specht, Alphonse G. Taghian
The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer
C. Villarreal-Garza, J. N. Weitzel, M. Llacuachaqui, E. Sifuentes, M. C. Magallanes-Hoyos, L. Gallardo, R. M. Alvarez-Gómez, J. Herzog, D. Castillo, R. Royer, Mohammad Akbari, F. Lara-Medina, L. A. Herrera, A. Mohar, S. A. Narod
Smoking and survival in female breast cancer patients
Alicia Padron-Monedero, Stacey L. Tannenbaum, Tulay Koru-Sengul, Feng Miao, Damien Hansra, David J. Lee, Margaret M. Byrne
Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies
Alessandra Gennari, Mauro Costa, Matteo Puntoni, Laura Paleari, Andrea De Censi, Maria Pia Sormani, Nicoletta Provinciali, Paolo Bruzzi
A comparison between different prediction models for invasive breast cancer occurrence in the French E3N cohort
Laureen Dartois, Émilien Gauthier, Julia Heitzmann, Laura Baglietto, Stefan Michiels, Sylvie Mesrine, Marie-Christine Boutron-Ruault, Suzette Delaloge, Stéphane Ragusa, Françoise Clavel-Chapelon, Guy Fagherazzi
The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes
Pauline A. J. Vissers, Chris R. Cardwell, Lonneke V. van de Poll-Franse, Ian S. Young, Frans Pouwer, Liam J. Murray
Elevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis
Jieqiong Liu, Wen Jiang, Kai Mao, Yi An, Fengxi Su, Betty Y. S. Kim, Qiang Liu, Lisa K. Jacobs
Frequent alterations of HER2 through mutation, amplification, or overexpression in pleomorphic lobular carcinoma of the breast
Huang-Chun Lien, Yu-Ling Chen, Yu-Lin Juang, Yung-Ming Jeng
Integrated analysis of DNA methylation, immunohistochemistry and mRNA expression, data identifies a methylation expression index (MEI) robustly associated with survival of ER-positive breast cancer patients
Jonine D. Figueroa, Howard Yang, Montserrat Garcia-Closas, Sean Davis, Paul Meltzer, Jolanta Lissowska, Hisani N. Horne, Mark E. Sherman, Maxwell Lee